These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 811822)

  • 1. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.
    JAMA; 1976 Jan; 235(3):261-5. PubMed ID: 811822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Chemoprophylaxis of meningococcal infections.
    Lancet; 1974 Dec; 2(7894):1431-2. PubMed ID: 4140338
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampin and minocycline in meningococcal disease.
    Beaty HN
    Rev Infect Dis; 1983; 5 Suppl 3():S451-8. PubMed ID: 6415780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland.
    Sivonen A; Renkonen OV; Weckström P; Koskenvuo K; Raunio V; Mäkelä PH
    J Infect Dis; 1978 Mar; 137(3):238-44. PubMed ID: 416147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of meningococcal meningitis].
    Wiesmann E; Rosselet F
    Schweiz Med Wochenschr; 1977 Jan; 107(1):13-6. PubMed ID: 401542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.
    Kaiser AB; Hennekens CH; Saslaw MS; Hayes PS; Bennett JV
    J Infect Dis; 1974 Sep; 130(3):217-24. PubMed ID: 4213375
    [No Abstract]   [Full Text] [Related]  

  • 11. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].
    Schubiger G; Munzinger J; Dudli C; Wipfli U
    Schweiz Med Wochenschr; 1986 Aug; 116(35):1172-5. PubMed ID: 3094142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin-resistant meningococcal disease.
    Rainbow J; Cebelinski E; Bartkus J; Glennen A; Boxrud D; Lynfield R
    Emerg Infect Dis; 2005 Jun; 11(6):977-9. PubMed ID: 15963302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing secondary cases of meningococcal disease by identifying and eradicating disease-causing strains in close contacts of patients.
    Kristiansen BE; Tveten Y; Ask E; Reiten T; Knapskog AB; Steen-Johnsen J; Hopen G
    Scand J Infect Dis; 1992; 24(2):165-73. PubMed ID: 1641593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
    Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
    J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of carriage of Neisseria meningitidis in families: a study in Brazil.
    Munford RS; Sussuarana de Vasconcelos ZJ; Phillips CJ; Gelli DS; Gorman GW; Risi JB; Feldman RA
    J Infect Dis; 1974 Jun; 129(6):644-9. PubMed ID: 4209720
    [No Abstract]   [Full Text] [Related]  

  • 18. Public health considerations in the management of meningococcal disease.
    McCormick JB; Bennett JV
    Ann Intern Med; 1975 Dec; 83(6):883-6. PubMed ID: 1106287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Additional note on the preventive use of antibacterial substances].
    Yourassowsky E
    Arch Belg Med Soc; 1973; 31(6):397-8. PubMed ID: 4495153
    [No Abstract]   [Full Text] [Related]  

  • 20. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers.
    Devine LF; Pollard RB; Krumpe PE; Hoy ES; Mammen RE; Miller CH; Peckinpaugh RO
    Am J Epidemiol; 1973 Jun; 97(6):394-401. PubMed ID: 4197420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.